Realta Investment Advisors Sells 69 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Realta Investment Advisors decreased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 3.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,775 shares of the biotechnology company’s stock after selling 69 shares during the period. Realta Investment Advisors’ holdings in Axon Enterprise were worth $1,067,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in AXON. Groupama Asset Managment purchased a new stake in Axon Enterprise in the third quarter worth approximately $200,000. Massachusetts Financial Services Co. MA bought a new stake in shares of Axon Enterprise in the 3rd quarter worth approximately $120,553,000. International Assets Investment Management LLC purchased a new stake in shares of Axon Enterprise in the 3rd quarter valued at $871,860,000. Westfield Capital Management Co. LP grew its holdings in shares of Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its position in Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after purchasing an additional 111,405 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the sale, the insider now directly owns 154,394 shares in the company, valued at $91,691,508.72. The trade was a 12.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,545 shares of company stock valued at $30,721,337. 5.70% of the stock is currently owned by corporate insiders.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $677.40 on Friday. Axon Enterprise, Inc. has a 1 year low of $255.68 and a 1 year high of $698.67. The stock has a market capitalization of $51.65 billion, a P/E ratio of 175.04, a P/E/G ratio of 6.54 and a beta of 1.05. The company’s 50-day moving average is $622.79 and its 200 day moving average is $491.30. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on AXON shares. Needham & Company LLC upped their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Robert W. Baird raised their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. TD Cowen assumed coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price on the stock. Finally, Northland Securities lifted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $542.15.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.